Google
AllImagesVideosNews Maps Shopping Books
Search tools

Patient Characteristics in Uncomplicated UTI Differ by Presence of ESBL Uropathogens

Renal and Urology News
In patients with uncomplicated UTI, the presence of positive vs negative ESBL uropathogens differed by symptom severity, race,...
1 day ago

Uncomplicated Urinary Tract Infections: The Latest Evidence and Patient Perspectives

PRIME® Continuing Medical Education
Uncomplicated urinary tract infections (uUTIs) are extremely common, but place tremendous burden on patients and healthcare systems, particularly in the...
4 months ago

Development and validation of a new scoring system to discriminate between uncomplicated and complicated appendicitis

Nature
A scoring system to discriminate between uncomplicated and complicated appendicitis is beneficial to determine the optimal treatment for...
3 months ago

Early Switch from IV to Oral Antibiotics for Uncomplicated Gram-Negative Bacteremia

The Hospitalist
Bottom line: Transitioning to oral antibiotics within four days after initial blood culture may be an effective alternative to prolonged...
1 month ago

Iterum’s Sulopenem receives FDA approval for treatment of uncomplicated urinary tract infections

2 Minute Medicine
Sulopenem was superior to amoxicillin/clavulanate and ciprofloxacin in treating antimicrobial resistant uncomplicated urinary tract...
3 weeks ago

Antibiotic duration and route for treatment of adults with uncomplicated streptococcal bloodstream infections: a retrospective study in a large healthcare system

ASM Journals
We found that 5–10-day courses were non-inferior to longer courses, and thus may be a safe and effective treatment option in the treatment of uncomplicated...
4 months ago

FDA approves new treatment for uncomplicated urinary tract infections

CIDRAP
FDA approves new treatment for uncomplicated urinary tract infections ... The US Food and Drug Administration (FDA) yesterday approved the oral...
7 months ago

Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial

The Lancet
LBP-EC01 is a novel, genetically enhanced, six-bacteriophage cocktail developed by Locus Biosciences (Morrisville, NC, USA) to address UTIs caused by...
3 months ago

FDA approves oral sulopenem for uncomplicated urinary tract infection

Urology Times
Oral sulopenem is the first oral penem approved in the U.S. for treating uUTIs in adult women with limited options. Approval is based on phase 3...
1 month ago

Uncomplicated TBAD: We need everyone in the centre for once

Vascular News
Firas Mussa (Houston, USA) urges specialists to put biases aside when it comes to treatment options for uncomplicated type B aortic...
3 weeks ago